Bruker (BRKR) Other Accumulated Expenses (2010 - 2026)

Bruker's Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $597.9 million for Q1 2026.

• Quarterly Other Accumulated Expenses rose 1.0% year-over-year to $597.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $597.9 million (up 1.0% YoY) and the FY2025 annual result came in at $605.4 million, up 1062.0% from the prior year.
• Other Accumulated Expenses was $597.9 million for Q1 2026 at Bruker, down from $605.4 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $605.4 million in Q4 2025 and bottomed at $52.1 million in Q4 2024.
• A 5-year average of $470.8 million and a median of $493.6 million in 2022 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses slumped 89.1% — and 2025, when it surged 1062.0%.
• Bruker's Other Accumulated Expenses stood at $347.0 million in 2022, then surged by 37.81% to $478.2 million in 2023, then slumped by 89.1% to $52.1 million in 2024, then jumped by 1062.0% to $605.4 million in 2025, then fell by 1.24% to $597.9 million in 2026.
• Business Quant data shows BRKR's Other Accumulated Expenses at $597.9 million in Q1 2026, $605.4 million in Q4 2025, and $604.0 million in Q3 2025.